Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Gareth Morgan to Septal Occluder Device

This is a "connection" page, showing publications Gareth Morgan has written about Septal Occluder Device.

 
Connection Strength
  
 
 
6.182
  
  1. Soszyn N, Zablah JE, Morgan GJ. Percutaneous closure of a left atrio-ventricular valve paravalvular leak with the Occlutech Paravalvular Leak Device in a 5-year-old child. Cardiol Young. 2025 Nov; 35(11):2406-2409.
    View in: PubMed
    Score: 0.901
  2. Minocha PK, Caputo M, Ramroop R, Morgan GJ. Use of the Occlutech pmVSD Device for Hybrid Closure of a Large Mid-Muscular Ventricular Septal Defect in a Small Infant Born With Hypoplastic Aortic Arch. World J Pediatr Congenit Heart Surg. 2024 01; 15(1):109-111.
    View in: PubMed
    Score: 0.775
  3. Zablah JE, Morgan GJ. Use of Occlutech® atrial flow regulator in a single ventricle patient: a 3D view of a successful intervention. Eur Heart J Cardiovasc Imaging. 2020 10 01; 21(10):1151.
    View in: PubMed
    Score: 0.630
  4. McLennan D, Ivy D, Morgan GJ. Transvenous implantation of the Occlutech Atrial Flow Regulator: Preliminary results from swine models. Congenit Heart Dis. 2019 Sep; 14(5):819-831.
    View in: PubMed
    Score: 0.580
  5. Goreczny S, Bedair R, Bilska K, Morgan G. Retrieving a large embolised atrial septal occluder - hooked? and landed. Kardiol Pol. 2017; 75(3):277.
    View in: PubMed
    Score: 0.486
  6. Morgan GJ. Occlutech® muscular ventricular septal defect device: the first reported human use. Cardiol Young. 2016 Oct; 26(7):1448-51.
    View in: PubMed
    Score: 0.468
  7. Smith B, Thomson J, Crossland D, Spence MS, Morgan GJ. UK multicenter experience using the Gore septal occluder (GSO(TM) ) for atrial septal defect closure in children and adults. Catheter Cardiovasc Interv. 2014 Mar 01; 83(4):581-6.
    View in: PubMed
    Score: 0.391
  8. Skinner GJ, Tulloh RM, Tometzki AJ, Schulze-Neick I, Morgan GJ. Atrial septal defect closure with an Amplatzer septal occluder fenestrated with a coronary stent in a child with pulmonary arterial hypertension. Cardiol Young. 2013 Oct; 23(5):692-6.
    View in: PubMed
    Score: 0.363
  9. Morgan G, Lee KJ, Chaturvedi R, Benson L. A biodegradable device (BioSTAR) for atrial septal defect closure in children. Catheter Cardiovasc Interv. 2010 Aug 01; 76(2):241-5.
    View in: PubMed
    Score: 0.311
  10. Malekzadeh-Milani S, Padovani P, Sivakumar K, Goronflot T, Méot M, Jones MI, Lwin N, Ovaert C, Hascoët S, Jalal Z, Bautista-Rodriguez C, Gewillig M, Lucron H, Averin K, Kahl BS, Gudnason JF, Torres AJ, Lefort B, Saliba Z, Houeijeh A, Galeczka M, Samion H, El Saiedi S, Lange JM, Yaakobi-Simhayoff N, Callegari A, Christensen AH, Ystgaard MB, Selly JB, Bouvaist H, Neil D, Sirico D, Karsenty C, Vargas-Acevedo C, Mejia E, Rosenthal E, Grunenwald C, Benbrik N, Werner O, Chauvire-Drouard A, Gloanec M, Moktadir A, Thambo JB, Brard M, Laforest G, Sagar P, Joseph A, Puthiyedath T, Holmstrom H, Fiszer R, Wåhlander H, Michel-Behnke I, Bonnet D, Gourraud PA, Butera G, Qureshi SA, Fraisse A, Morgan GJ, Baruteau AE. Outcomes of transcatheter patent ductus arteriosus closure in infants weighing 2 to 6 kg. Rev Esp Cardiol (Engl Ed). 2026 Apr; 79(4):316-328.
    View in: PubMed
    Score: 0.223
  11. Soszyn N, Gill EA, Zablah JE, Morgan GJ. Transcatheter closure of a right pulmonary artery to left atrium fistula using multi-modality image fusion guidance. Cardiol Young. 2024 Dec; 34(12):2712-2715.
    View in: PubMed
    Score: 0.210
  12. Qureshi AM, Sommer RJ, Morgan G, Paolillo JA, Gray RG, Love B, Goldstein BH, Sugeng L, Gillespie MJ. Long-Term Results of the Atrial Septal Defect Occluder ASSURED Trial for Combined Pivotal/Continued Access Cohorts. JACC Cardiovasc Interv. 2024 Oct 14; 17(19):2274-2283.
    View in: PubMed
    Score: 0.207
  13. Sommer RJ, Love BA, Paolillo JA, Gray RG, Goldstein BH, Morgan GJ, Gillespie MJ. ASSURED clinical study: New GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv. 2020 06 01; 95(7):1285-1295.
    View in: PubMed
    Score: 0.150
  14. Goreczny S, Morgan GJ, Dryzek P. Live 3D image overlay for arterial duct closure with Amplatzer Duct Occluder II additional size. Cardiol Young. 2016 Mar; 26(3):605-8.
    View in: PubMed
    Score: 0.111
  15. Kang SL, Tometzki A, Caputo M, Morgan G, Parry A, Martin R. Longer-term outcome of perventricular device closure of muscular ventricular septal defects in children. Catheter Cardiovasc Interv. 2015 May; 85(6):998-1005.
    View in: PubMed
    Score: 0.106
  16. Kang SL, Morgan G, Forsey J, Tometzki A, Martin R. Long-term clinical experience with Amplatzer Ductal Occluder II for closure of the persistent arterial duct in children. Catheter Cardiovasc Interv. 2014 Jun 01; 83(7):1102-8.
    View in: PubMed
    Score: 0.099
  17. Thomson JD, Hildick-Smith D, Clift P, Morgan G, Daniels M, Henderson R, Spence MS, Mahadevan VS, Crossland D, Ormerod O. Patent foramen ovale closure with the Gore septal occluder: initial UK experience. Catheter Cardiovasc Interv. 2014 Feb 15; 83(3):467-73.
    View in: PubMed
    Score: 0.097
  18. Forsey J, Kenny D, Morgan G, Hayes A, Turner M, Tometzki A, Martin R. Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct. Catheter Cardiovasc Interv. 2009 Oct 01; 74(4):615-23.
    View in: PubMed
    Score: 0.073
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)